NO924929L - Farmasoeytisk aktive benzoquinazolinforbindelser - Google Patents

Farmasoeytisk aktive benzoquinazolinforbindelser

Info

Publication number
NO924929L
NO924929L NO92924929A NO924929A NO924929L NO 924929 L NO924929 L NO 924929L NO 92924929 A NO92924929 A NO 92924929A NO 924929 A NO924929 A NO 924929A NO 924929 L NO924929 L NO 924929L
Authority
NO
Norway
Prior art keywords
group
compounds
pharmasoeytic
active
optionally substituted
Prior art date
Application number
NO92924929A
Other languages
English (en)
Norwegian (no)
Other versions
NO924929D0 (no
Inventor
William Pendergast
Scott Howard Dickerson
Julius Vass Johnson
Robert Ferone
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO924929L publication Critical patent/NO924929L/no
Publication of NO924929D0 publication Critical patent/NO924929D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO924929A 1990-06-19 1992-12-18 Farmasoeytisk aktive benzoquinazolinforbindelser NO924929D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909013615A GB9013615D0 (en) 1990-06-19 1990-06-19 Pharmaceutical compounds
PCT/GB1991/000977 WO1991019700A1 (en) 1990-06-19 1991-06-18 Pharmaceutically active benzoquinazoline compounds

Publications (2)

Publication Number Publication Date
NO924929L true NO924929L (no) 1992-12-18
NO924929D0 NO924929D0 (no) 1992-12-18

Family

ID=10677828

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924929A NO924929D0 (no) 1990-06-19 1992-12-18 Farmasoeytisk aktive benzoquinazolinforbindelser

Country Status (26)

Country Link
US (4) US6090941A (xx)
EP (2) EP0535034B1 (xx)
JP (1) JP2966929B2 (xx)
KR (1) KR0183042B1 (xx)
CN (1) CN1049215C (xx)
AP (1) AP218A (xx)
AT (2) ATE222243T1 (xx)
AU (1) AU639815B2 (xx)
CA (1) CA2085589C (xx)
CS (1) CS186391A3 (xx)
DE (2) DE69133088T2 (xx)
DK (2) DK1199307T3 (xx)
ES (2) ES2178632T3 (xx)
FI (1) FI925778A (xx)
GB (1) GB9013615D0 (xx)
HU (2) HUT62273A (xx)
IE (1) IE912073A1 (xx)
IL (1) IL98542A (xx)
MC (1) MC2290A1 (xx)
MY (1) MY107001A (xx)
NO (1) NO924929D0 (xx)
NZ (1) NZ238582A (xx)
PL (1) PL169927B1 (xx)
PT (1) PT98021B (xx)
WO (1) WO1991019700A1 (xx)
ZA (1) ZA914676B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9013615D0 (en) 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
US6420344B1 (en) 1999-03-16 2002-07-16 The Regents Of The University Of California Glycosylated polyamines
US6531454B1 (en) 1999-03-16 2003-03-11 The Regents Of The University Of California Glycosylated polyamines and methods of use therefor
IL153230A0 (en) * 2000-06-09 2003-07-06 Osi Pharm Inc Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
PL369567A1 (en) * 2001-09-26 2005-05-02 Bayer Pharmaceuticals Corporation 1,6-naphthyridine derivatives as antidiabetics
CN100434425C (zh) * 2005-03-09 2008-11-19 首都师范大学 4-喹唑啉酮衍生物及其在抗肿瘤药物中的应用
EP1754484A1 (en) * 2005-08-17 2007-02-21 Dan Stoicescu Condensed pyrimidine derivatives as inhibitors of foic acid-dependent enzymes
CA2631704A1 (en) 2005-12-05 2007-06-14 Nitto Denko Corporation Polyglutamate-amino acid conjugates and methods
GB0525069D0 (en) * 2005-12-08 2006-01-18 Novartis Ag Organic compounds
MX2009003673A (es) 2006-10-04 2009-04-22 Pfizer Prod Inc Derivados de piridido[4,3-d]pirimidin-4(3h)-ona como antagonistas de los receptores de calcio.
EP1958632A1 (en) 2007-02-14 2008-08-20 Dan Stoicescu Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases
CN101678123B (zh) 2007-05-09 2014-07-16 日东电工株式会社 包含疏水性化合物和聚氨基酸结合物的组合物
JP2010526917A (ja) * 2007-05-09 2010-08-05 日東電工株式会社 複数種の薬物を有するポリグルタミン酸塩複合体及びポリグルタミン酸塩−アミノ酸複合体
JP2010528122A (ja) * 2007-05-09 2010-08-19 日東電工株式会社 白金薬剤と結合されたポリマー
US8146622B2 (en) 2007-08-20 2012-04-03 Ford Global Technologies, Llc Switch and hose-valve connection arrangement for vehicle temporary mobility kit
US8517760B2 (en) 2007-08-20 2013-08-27 Ford Global Technologies, Llc Cord wrap and power plug receptacle arrangement for inflator
WO2010138955A2 (en) 2009-05-29 2010-12-02 University Of Florida Research Foundation, Inc. Methods and compositions for treating neoplasia
CN101580501B (zh) * 2009-06-01 2011-03-09 南京卡文迪许生物工程技术有限公司 3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体
WO2011078226A1 (ja) * 2009-12-22 2011-06-30 協和発酵キリン株式会社 三環系化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UST862021I4 (en) * 1969-01-27 1969-05-27 Defensive publication
ZA72442B (en) * 1971-02-05 1972-10-25 Apaw Sa Automatic ice-cream machine
GB2065653B (en) * 1979-12-19 1983-03-09 Nat Res Dev Anti-cancer quinazoline derivatives
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
US4603186A (en) 1985-10-21 1986-07-29 The Standard Oil Company Tetrapolymers containing indene
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
US4902624A (en) * 1987-11-23 1990-02-20 Eastman Kodak Company Temperature cycling cuvette
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
US5405851A (en) * 1990-06-19 1995-04-11 Burroughs Wellcome Co. Pharmaceutical compounds

Also Published As

Publication number Publication date
JPH05507704A (ja) 1993-11-04
KR930701415A (ko) 1993-06-11
HU211265A9 (en) 1995-11-28
ATE222243T1 (de) 2002-08-15
PT98021A (pt) 1992-04-30
CA2085589C (en) 2001-12-18
CS186391A3 (en) 1992-04-15
MC2290A1 (fr) 1993-07-14
GB9013615D0 (en) 1990-08-08
IE912073A1 (en) 1992-01-01
CN1049215C (zh) 2000-02-09
NZ238582A (en) 1993-12-23
FI925778A0 (fi) 1992-12-18
DK0535034T3 (da) 2002-12-09
CA2085589A1 (en) 1991-12-20
JP2966929B2 (ja) 1999-10-25
US6306865B1 (en) 2001-10-23
AP218A (en) 1992-09-27
NO924929D0 (no) 1992-12-18
PT98021B (pt) 1998-11-30
ES2211851T3 (es) 2004-07-16
EP1199307B1 (en) 2004-02-25
AP9100283A0 (en) 1991-07-31
ATE260262T1 (de) 2004-03-15
DE69133088T2 (de) 2003-03-20
US5661155A (en) 1997-08-26
FI925778A (fi) 1992-12-18
IL98542A (en) 1995-05-26
ES2178632T3 (es) 2003-01-01
CN1058208A (zh) 1992-01-29
US6090941A (en) 2000-07-18
AU8094391A (en) 1992-01-07
AU639815B2 (en) 1993-08-05
PL169927B1 (pl) 1996-09-30
EP0535034A1 (en) 1993-04-07
KR0183042B1 (ko) 1999-05-01
ZA914676B (en) 1993-02-24
DE69133088D1 (de) 2002-09-19
DK1199307T3 (da) 2004-06-14
DE69133371T2 (de) 2005-01-27
EP0535034B1 (en) 2002-08-14
EP1199307A1 (en) 2002-04-24
DE69133371D1 (de) 2004-04-01
HUT62273A (en) 1993-04-28
WO1991019700A1 (en) 1991-12-26
HU9204011D0 (en) 1993-03-29
MY107001A (en) 1995-08-30
IL98542A0 (en) 1992-07-15
US5663337A (en) 1997-09-02

Similar Documents

Publication Publication Date Title
NO924929L (no) Farmasoeytisk aktive benzoquinazolinforbindelser
HUT74367A (en) Fungicidal alpha-aryl-substituted cyclic amide derivatives, fungicid compositions containing these as active ingredients and using thereof
HUP9802814A2 (hu) Szelektív béta3 adrenergiás agonista hatású vegyületek, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
CA2036304A1 (en) Pyrimidinedione derivatives, their production and use
HUP9903766A2 (en) Pyridyl alkene- and pyridyl alkine- acid amides, use of them as cytostatics and immunosuppressives, process for their preparation and pharmaceuticals containing the same
ES482134A1 (es) Un procedimiento para preparar derivados de 1-(3-mercapto- 2-metilpropanoil)-prolil-aminoacido.
MY119118A (en) Thiophenopyrimidines
EP0324387A3 (en) Composition for treatment of ischemic disorder in organs
NO996108L (no) 9-oksinerytromycinderivater
DK142084A (da) N-phenyl-n'-cycloalkylalkanoyl-piperaziner og fremgangsmaade til fremstilling heraf
DK151627C (da) Analogifremgangsmaade til fremstilling af terapeutisk virksomme 4-(fenylalkenyl)-imidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf.
HUP9902017A2 (hu) Aminosav- és hidroxisav-származékokkal szubsztituált benzamidinszármazékok és antikoagulánsokként történő alkalmazásuk
NO812355L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DE3362504D1 (en) 1-carboxyalkanoylindoline-2-carboxylic-acid esters, their preparation, pharmaceutical compositions containing them, and their therapeutic use
HK56597A (en) 3-aminochromane derivatives procedure for their preparation and pharmaceutical compositions containing them
DK469687A (da) Derivater af 4,5-dihydrooxazoler og fremgangsmaade til fremstilling af saadanne derivater.
GB8829593D0 (en) Novel compounds
ES8606880A1 (es) Un procedimiento para la preparacion de nuevos peptidos.
AU4304596A (en) A process for the preparation of substituted 4-ethyl-piperidines and an intermediate for the preparation of same
NO923004D0 (no) 6-oxo-azepinoindolforbindelser, saavel som fremgangsmaater og mellomprodukter for fremstilling av disse, og legemidler inneholdende disse forbindelser
HUP0104533A2 (hu) Új pirimidinszármazékok és eljárás ezek előállítására és ezeket tartalmazó gyógyszerkészítmények
NO20003138L (no) Ny anvendelse av lokalanestetika mot vaskulære hodepiner
TR200000154T2 (tr) 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler.
MY106786A (en) Novel antiviral tetrahydroimidazo [1,4] benzodiazepin -2- (thi)ones